A Phase II Study of Antineoplastons A10 and AS2-1 in Children with Low-Grade Astrocytomas

Journals Menu

Follow SCIRP

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.org/journal/jct
E-mail: jct@scirp.org

Citations h5-index & Ranking

"A Phase II Study of Antineoplastons A10 and AS2-1 in Children with Low-Grade Astrocytomas—Final Report (Protocol BT-13)"
written by Stanislaw R. Burzynski, Tomasz J. Janicki, Gregory S. Burzynski,
published by Journal of Cancer Therapy, Vol.7 No.12, 2016

has been cited by the following article(s):

[1]	A 25-year-female with Diffuse Intrinsic Pontine Glioma Surviving for More than Nine Years Following Treatment with Antineoplastons
	Cancer …, 2022

[2]	Newly-Diagnosed Multicentric Pilocytic Astrocytoma: Complete Response and> 22 Years Survival in a Six Year and Nine-Month-Old Female Treated with …
	Internat J Clin Oncol …, 2022

[3]	Newly Diagnosed Glioblastoma: Partial Response and> 27 Years Overall Survival in 37-Year-Old Male Treated with Antineoplastons (Treatment of …
	Recent Adv Clin Trials, 2022

[4]	Resolution of clinical signs, a complete response, and long-term survival (> 23 Years) in a 3 and ½ month female with a newly diagnosed diffuse intrinsic …
	Biomed Res, 2021

[5]	Long-term survival (23 years) in a 26-year-old male after Antineoplaston therapy for a progressive, diffuse intrinsic pontine glioma: A case report
	Int J Brain Disord …, 2021

[6]	A Phase II Study of Antineoplastons A10 and AS2-1 in Children with Brain Tumors. Final Report (Protocol BT-10)
	2017

[7]	Antineoplastons A10 and AS2-1 in the Treatment of Children with Optic Pathway Glioma: Final Report for Protocol BT-23
	2017

Follow SCIRP